Doctor Jason Finkelstein Accused in $89 Million Cardiovascular Testing Scheme Targeting College Athletes

Federal prosecutors allege that unnecessary EKG, echocardiogram, and vascular ultrasound testing was promoted to college athletes as potentially lifesaving screening, then supported with false diagnoses and physician approvals to generate reimbursements from private and public health plans nationwide.

WASHINGTON, DC— Federal prosecutors have accused Doctor Jason Finkelstein, a Fort Worth cardiologist licensed across the 48 contiguous states, of helping operate an $89 million cardiovascular testing scheme that allegedly transformed college athletes’ fears about sudden cardiac arrest into fraudulent insurance claims.

The indictment alleges that Finkelstein and two unnamed co-conspirators arranged recurring campus testing, used diagnoses that athletes supposedly did not have, misrepresented where services occurred, and approved results without meaningful review before claims traveled electronically to government programs and commercial insurers.

Authorities say the operation submitted more than $89 million in claims between January 2019 and December 2025, generating approximately $13.1 million in payments, although prosecutors separately allege that Finkelstein personally received approximately $1.1 million from reimbursements collected by participating entities.

Finkelstein has pleaded not guilty, remains presumed innocent, and is entitled to challenge every accusation, witness, record, expert conclusion, and financial calculation before prosecutors can obtain a conviction under the demanding beyond-a-reasonable-doubt standard governing federal criminal trials.

Federal indictment describes a nationwide testing operation

Houston Chronicle reporting on the Jason Finkelstein allegations identified the case as part of a broader federal healthcare fraud crackdown, while emphasizing prosecutors’ claim that the alleged operation reached student athletes and families on school campuses throughout the United States.

Finkelstein, who was 53 when charged, allegedly served as medical director for an unnamed cardiovascular testing company and owned Cardiovascular Testing Services PA and Cardiovascular Healthcare Associates PA, two Texas professional associations operating primarily from Tarrant County.

According to prosecutors, those organizations presented cardiovascular examinations as no-cost screening capable of detecting dangerous abnormalities, while their business model depended upon obtaining reimbursement from insurers that generally required an individualized medical basis before covering diagnostic procedures.

The government contends that this gap between broad screening and reimbursable diagnostic care was allegedly bridged through false diagnoses, inaccurate provider representations, standardized testing panels, and electronic approvals carrying the authority of a board-certified cardiologist with nationwide licensing.

The indictment does not accuse every cardiovascular screening program of misconduct, nor does it suggest that every test offered to an athlete lacks value, because the charged theory focuses upon allegedly unnecessary services, false information, deficient review, and intentional deception.

Fear of sudden cardiac arrest allegedly drove campus marketing

Prosecutors allege that marketers approached college athletic personnel with warnings that apparently healthy competitors could collapse from sudden cardiac arrest, presenting the offered tests as a compelling protective measure for schools, teams, athletes, and worried families seeking reassurance.

The operation allegedly sent communications to athletic trainers describing testing that could identify life-threatening conditions capable of preventing participation, linking an emotionally powerful safety message to a program whose ultimate revenue came from health-plan reimbursements rather than direct student payments.

Federal authorities further claim that checks, wire payments, gift cards, or other inducements were offered to athletic directors and other campus personnel for referrals, although the indictment leaves the alleged co-conspirators unnamed and does not publicly identify every participating institution.

Some athletes were allegedly told the cardiovascular examinations were mandatory for continued participation, a representation that could have transformed an apparently optional screening opportunity into a practical requirement for students whose scholarships, team roles, education, or future ambitions depended upon competing.

That alleged recruitment strategy gives the Jason Finkelstein case a distinctive human dimension, because prosecutors describe young patients responding to institutional authority and genuine medical anxiety rather than beneficiaries knowingly seeking unnecessary equipment, prescriptions, or services for personal advantage.

The same six tests were allegedly repeated for most athletes

Sonographers working for the testing company allegedly traveled to campuses and performed substantially the same six cardiovascular tests on almost every student-athlete, including electrocardiograms, echocardiograms, and multiple vascular ultrasound studies billed through the companies associated with Finkelstein.

An electrocardiogram records electrical activity and rhythm, while an echocardiogram uses ultrasound to produce moving images of cardiac structures, meaning the services examine different aspects of cardiovascular function and can generate records requiring individualized professional interpretation before responsible clinical conclusions.

Prosecutors allege that some sonographers lacked the credentials required for the work they performed, and that no doctor conducted the clinical examination or assessment needed to determine whether each athlete’s symptoms, medical history, physical findings, or circumstances warranted the full panel.

The alleged uniformity matters because medical necessity ordinarily turns upon an individual patient’s condition and the applicable plan’s coverage rules, whereas a recurring package delivered across campuses may appear to investigators more like a revenue template than patient-specific diagnostic decision-making.

Defense lawyers can contest that characterization by examining actual questionnaires, symptoms, protocols, credentials, plan language, physician communications, and recognized screening practices, since repetition across a population does not alone establish fraudulent intent or prove that every service lacked clinical justification.

False diagnoses allegedly converted screening into payable claims

The government alleges that diagnoses were assigned to completed student questionnaires so company billers could submit claims portraying the tests as medically necessary, even when athletes supposedly did not have the hypertension, elevated blood pressure, or other conditions recorded for reimbursement purposes.

Those allegations place coding at the center of the prosecution because a diagnostic label can determine whether a health plan treats an examination as covered medical care, noncovered preventive screening, an unsupported claim requiring further documentation, or a submission eligible for denial.

The claims allegedly reached commercial insurance plans, the Federal Employees Health Benefits Program, the Veterans Health Administration, and Medicaid, demonstrating that the accused billing activity crossed both private and publicly supported systems rather than depending exclusively upon one federal insurance program.

False clinical information can also create consequences beyond immediate payment because diagnoses may follow patients through medical records, insurer databases, eligibility reviews, future treatment decisions, or risk assessments, although the indictment’s criminal counts concentrate upon allegedly fraudulent claims rather than every possible downstream effect.

Prosecutors must still prove that Finkelstein knowingly joined the charged agreement and acted with fraudulent intent, because incorrect coding, careless documentation, disputed medical necessity, or mistakes by other participants would not automatically establish every element of conspiracy or substantive healthcare fraud.

Finkelstein allegedly appeared as the ordering physician

The Justice Department’s official Jason Finkelstein case page says he was the only ordering or referring provider identified for the cardiovascular testing claims, despite allegedly conducting no clinical examination to determine whether athletes had symptoms supporting the services.

That accusation is central because the ordering provider provides the medical authority that connects a patient’s circumstances to a requested diagnostic procedure, while insurers rely on provider information to decide whether submitted services meet contractual, regulatory, and medical-necessity requirements.

Finkelstein’s licenses in the 48 contiguous states allegedly enabled the participating companies to submit claims involving students at schools nationwide, giving the operation geographic reach that a physician licensed in only one or two jurisdictions could not readily provide.

The government additionally alleges that place-of-service codes falsely located some testing at Finkelstein’s office in Tarrant County, Texas, even though traveling sonographers had actually performed the procedures on college campuses elsewhere in the United States.

If proved, those combined representations could help prosecutors argue that the alleged fraud was designed into the claims process through provider identity, diagnostic coding, service location, and review status, rather than arising from isolated clerical errors occurring after legitimate care.

Electronic approvals allegedly occurred within seconds

Prosecutors say Finkelstein used an electronic platform to sign and approve cardiovascular results as normal within seconds of accessing the material, even when the underlying studies included numerous images that would ordinarily require careful evaluation before a reliable professional conclusion.

The indictment alleges that claims represented Finkelstein as the reviewing provider when he had not meaningfully reviewed the studies, linking rapid electronic approvals to reimbursement requests that supposedly relied on completed physician interpretation as part of the billed service.

An August 2022 text exchange described in the charging document allegedly showed Finkelstein acknowledging that he did not interpret abdominal aorta ultrasounds routinely performed and billed by the company, yet claims for those services allegedly continued until approximately January 2024.

Electronic metadata may therefore become especially important at trial because access times, signature events, image volumes, user credentials, audit logs, and workflow records could help jurors evaluate whether meaningful review occurred and who controlled each step of approval.

The defense can challenge whether platform timestamps capture preparation performed elsewhere, whether another professional completed preliminary review, whether credentials were shared or attributed correctly, and whether prosecutors have interpreted the technical records within the full clinical and operational context.

Athlete’s death gives the allegations exceptional gravity

The most consequential allegation concerns a student athlete identified by initials whose October 2024 testing produced approximately 63 images, including preliminary indications of possible right-sided heart enlargement, before Finkelstein allegedly signed the entire collection as normal after approximately eleven seconds.

Approximately 24 days later, prosecutors say the athlete died from sudden cardiac arrest while exercising with his basketball team, creating a devastating sequence that authorities cite as evidence that the alleged conduct threatened patient safety alongside insurer finances.

The indictment further alleges that Finkelstein continued approving other student results without meaningful review after learning about the death and the family’s concerns, an assertion likely to receive close examination through communications, audit records, witness testimony, and cardiology experts.

That tragedy does not independently prove healthcare fraud, negligent review, or criminal causation, because the government must establish the charged legal elements while medical experts may dispute what the images showed, what action was required, and what caused the fatal event.

Responsible coverage must therefore acknowledge both realities simultaneously, recognizing the profound seriousness of the alleged missed abnormality while preserving the defendant’s right to contest causation, professional standards, electronic evidence, and the prosecution’s interpretation before an impartial jury.

Claims submitted and money paid are different measurements

The headline figure represents more than $89 million in allegedly false claims submitted, not money prosecutors say Finkelstein personally received, and that distinction is essential to accurately describe the scale, alleged loss, potential restitution, forfeiture, and individual benefit.

Health plans allegedly paid approximately $13.1 million into accounts belonging to Cardiovascular Testing Services and Cardiovascular Healthcare Associates, meaning most claimed amounts were not reimbursed and may have been denied, rejected, reduced, or otherwise left unpaid.

Finkelstein allegedly received approximately $1.1 million through checks and wires funded by reimbursements collected by the participating entities, while prosecutors claim the broader proceeds benefited conspirators, supported operations, and furthered the charged agreement over almost seven years.

The forfeiture section seeks a money judgment of approximately $13.15 million if the government obtains a conviction and establishes the required connection between the property and the offenses, but an indictment request is not a forfeiture order.

Restitution, forfeiture, loss calculations, personal gain, and amounts billed can overlap without becoming interchangeable, so any eventual financial judgment would depend upon evidence, statutory rules, judicial findings, available assets, and the precise offenses resolved through trial or plea.

Four federal counts focus the government’s case

Count One alleges a conspiracy to commit healthcare fraud and wire fraud from approximately January 2019 through December 2025, while Counts Two through Four charge substantive healthcare fraud connected with three particular claims identified in the indictment.

The first two substantive claims allegedly involved abdominal aorta ultrasounds billed at about $150 each in October 2023 and January 2024, while the third involved a $975 combination of EKG, echocardiogram, and vascular ultrasound services performed in October 2024.

The relatively modest amounts attached to those three examples do not limit the conspiracy allegation to $1,275, because prosecutors use specific claim transactions as charged executions within a broader operation allegedly responsible for tens of millions in submissions.

At trial, prosecutors must connect those claims and the larger agreement to Finkelstein through records and testimony establishing knowledge, intent, participation, material falsehoods, interstate wire activity, and the delivery or payment of healthcare benefits covered by federal law.

The defense may answer by challenging billing responsibility, corporate roles, clinical support, witness credibility, data interpretation, communications, causation, and the conduct of unnamed participants, while arguing that professional or administrative failures do not necessarily amount to intentional federal crimes.

Alleged concealment extended beyond individual claims

The indictment alleges that Finkelstein and others prepared false documentation when insurers denied claims, suggesting that the accused operation did not simply submit initial bills but also pursued appeals intended to overcome scrutiny and secure payment after rejection.

Prosecutors further claim that additional companies were formed to circumvent efforts by insurers and government programs to prevent fraudulent billing, while claims were routed through Finkelstein’s professional associations to conceal an unnamed co-conspirator’s continuing involvement in the testing enterprise.

Those allegations could allow the government to present corporate formation, billing changes, and appeal records as evidence of consciousness and continuity, although legitimate businesses also restructure or contest denials for lawful reasons that the defense may emphasize.

Financial records, ownership documents, communications, contracts, credentialing files, and insurer correspondence will consequently matter because jurors may need to decide whether each organizational change reflected ordinary business adaptation, regulatory compliance, or deliberate concealment of fraudulent activity.

The unnamed co-conspirators remain important to that analysis because their decisions, compensation, communications, and possible cooperation could shape the government’s narrative, while Finkelstein may contend that others controlled marketing, staffing, coding, billing, or disputed operational details.

Case emerged from a historic national enforcement action

Federal officials announced Finkelstein’s prosecution during a 2026 national healthcare fraud takedown involving charges against 455 defendants and more than $6.5 billion in alleged false claims, placing the athlete-testing case within an exceptionally broad enforcement campaign.

That nationwide initiative included physicians, other licensed professionals, company owners, marketers, billers, and alleged money launderers accused in unrelated schemes involving wound products, durable medical equipment, hospice care, genetic testing, behavioral services, and numerous additional benefit categories.

The scale of the takedown does not provide evidence against Finkelstein, because each prosecution depends on its own admissible proof and individualized legal analysis, but the context illustrates federal investigators’ growing reliance on claims data, electronic records, and coordinated agency review.

Healthcare fraud investigations increasingly compare billing patterns across providers, locations, diagnoses, patient populations, and service combinations, allowing unusual volumes or repeated coding relationships to generate investigative leads that must still be supported through witnesses, records, and lawful process.

College athletes occupied a vulnerable position

Student athletes often rely upon trainers, coaches, medical personnel, schools, and insurers to interpret health requirements, meaning an official-looking campus program can carry authority that makes independent questioning difficult even when participation is described as preventive or free.

The phrase no cost can also obscure who ultimately pays, because an athlete may owe nothing at the testing site while a family’s private coverage, a public benefit program, an employer-supported plan, or taxpayers receive and finance resulting claims.

Prosecutors portray that separation as central to the alleged business model, since the operation supposedly obtained patient participation through safety messaging while directing the financial transaction toward insurers whose coverage criteria depended upon truthful diagnoses and provider representations.

Schools reviewing the allegations may consequently examine vendor screening, referral arrangements, proof of licensure, sonographer credentials, informed consent, medical oversight, data handling, billing disclosures, and procedures for communicating abnormal findings to athletes and families.

Those institutional lessons remain appropriate even before guilt is decided, because stronger verification and transparent billing rules can protect patients and health plans without presuming that every person, school, or company associated with a questioned program knowingly participated in wrongdoing.

Presumption of innocence governs the prosecution

Finkelstein’s not-guilty plea requires prosecutors to prove every charged offense beyond a reasonable doubt, while the indictment itself remains an accusation approved for prosecution rather than evidence establishing that jurors must accept the government’s description of disputed events.

Defense attorney Jonathan Meltz has publicly challenged a proposed bond condition seeking to stop Finkelstein from practicing medicine entirely, although a pretrial employment dispute does not determine whether the charged testing, coding, review, and billing allegations are true.

Complex healthcare cases often involve enormous datasets, multiple corporate actors, specialized terminology, varying insurer requirements, and contested expert opinions, making discovery and motion practice essential to separate potentially fraudulent representations from negligence, ambiguity, delegation, or ordinary billing disagreements.

Jurors could eventually hear from athletes, families, trainers, sonographers, billers, company employees, investigators, insurers, cardiologists, data specialists, and custodians of electronic systems, subject to judicial decisions about relevance, reliability, privacy, admissibility, and procedural fairness.

Until that evidence is tested or the case ends through another lawful resolution, responsible reporting should attribute each disputed assertion to prosecutors, distinguish allegation from proof, and avoid converting the emotional power of a student’s death into a premature criminal judgment.

Current schedule points toward an April 2027 trial

The Justice Department’s current public information schedules a September 16, 2026 status conference, a March 30, 2027 calendar call, and an April 5, 2027 trial before United States District Judge Aileen Cannon in West Palm Beach.

That extended timetable reflects the potential complexity of reviewing medical images, claims histories, company records, insurer rules, electronic communications, financial transfers, and expert evidence accumulated during an alleged operation spanning nearly seven years and numerous states.

Pretrial litigation could address discovery volume, patient privacy, expert deadlines, hearsay, electronic authentication, medical-necessity standards, alleged inducements, corporate records, financial calculations, and whether evidence surrounding the athlete’s death is admissible for every purpose the prosecutor may propose.

The court may also revisit release conditions if circumstances change, but any occupational restriction remains a preventive pretrial measure, not a substitute for licensing discipline, civil liability, or the criminal verdict jurors may eventually reach.

Lawful mobility cannot erase pending federal obligations

The case also reflects the principle discussed in Amicus International’s examination of lawful identity-change myths: a legitimate change of name, residence, citizenship, or personal documentation never cancels an indictment, court order, financial obligation, or requirement to appear.

Amicus International’s explanation of United States extradition procedures similarly describes formal processes governing cross-border surrender, reinforcing that international travel cannot lawfully be used to defeat judicial supervision, conceal assets, frustrate forfeiture, or avoid a pending prosecution.

This article examines no public allegation that Finkelstein attempted to flee, hide his location, or violate release, and these broader principles clarify the continuing reach of court obligations without suggesting misconduct prosecutors have not charged.

Anyone facing federal proceedings must comply with travel limits, reporting duties, employment restrictions, document-surrender requirements, and scheduled appearances, and must obtain legal advice and court permission before taking actions that could conflict with enforceable release conditions.

What investigators and lawyers will examine next

Prosecutors will likely organize the case around claims data, marketing communications, payment records, test images, electronic approvals, campus relationships, provider identifiers, corporate structures, and testimony explaining how the accused workflow allegedly converted broad screening into reimbursable diagnostic services.

Defense lawyers can test whether the government has attributed decisions accurately, interpreted messages fairly, accounted for preliminary clinical work, applied each insurer’s rules correctly, established deficient credentials, and distinguished Finkelstein’s conduct from responsibilities assigned to other participants.

Expert cardiologists may become essential when evaluating whether particular studies showed abnormalities, how much review was clinically necessary, whether preliminary notations required escalation, and whether the athlete’s later death can be connected reliably to an alleged approval failure.

Insurance experts may separately address medical-necessity rules, diagnosis requirements, place-of-service coding, claim appeals, payment methodologies, and materiality, because a medically disputed service does not become criminally fraudulent unless prosecutors prove the additional statutory elements and required intent.

Financial specialists may trace the approximately $13.1 million in reimbursements through company accounts, alleged payments to Finkelstein, operational expenses, participant transfers, and assets targeted for forfeiture, while the defense scrutinizes whether every dollar carries the characterization prosecutors assign.

A prosecution testing trust in medicine and college athletics

The Jason Finkelstein case stands apart from conventional billing prosecutions because its allegations combine youth athletics, sudden-death fears, nationwide physician licensing, campus access, standardized diagnostic testing, electronic approval, false clinical information, and a fatal outcome prosecutors connect to deficient review.

For families, the central concern is whether a program promising reassurance actually delivered careful cardiovascular evaluation; insurers will focus on whether truthful records supported every claim; and schools will examine how outside medical vendors gained credibility and access.

For the government, the prosecution must translate a sprawling alleged operation into admissible proof showing Finkelstein knowingly joined and advanced fraud, while the defense retains every opportunity to expose unreliable witnesses, unsupported assumptions, technical gaps, and reasonable alternative explanations.

The $89 million headline communicates extraordinary billing scale, but the case’s lasting significance may ultimately depend upon whether prosecutors prove that medical authority intended to protect athletes was knowingly used to support unnecessary testing, false reimbursements, and dangerously superficial review.

Until a jury reaches a verdict or another lawful resolution ends the proceeding, Finkelstein remains presumed innocent, the financial figures remain allegations, and the federal court must evaluate the evidence without allowing public outrage or institutional concern to replace proof beyond a reasonable doubt.